TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionProShare Advisors LLC
Latest Disclosed Ownership22,500 shares
Latest Disclosed Value $ 747,451
ProShare Advisors LLC reports 20.01% decrease in ownership of 1TGTX / TG Therapeutics, Inc.

On April 24, 2026 - ProShare Advisors LLC filed a 13F-HR form disclosing ownership of 22,500 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $622,350 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 28,130 shares of TG Therapeutics, Inc.. This represents a change in shares of -20.01% during the quarter. The current value of the position is $765,000 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F TG THERAPEUTICS COM 88322Q108 22,500 -5,630 -20.01 747 -10.86 0.0011
2026-02-06 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 28,130 936 3.44 839 -14.66 0.0015
2025-11-06 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 27,194 -5,051 -15.66 982 -15.34 0.0021
2025-08-07 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 32,245 -516 -1.58 1,160 -10.15 0.0023
2025-05-08 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 32,761 -9,194 -21.91 1,292 2.30 0.0029
2025-02-14 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 41,955 12,951 44.65 1,263 86.14 0.0029
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 29,004 10,429 56.15 678 105.45 0.0017
2024-08-13 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 18,575 -6,339 -25.44 330 -12.70 0.0009
2024-05-08 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 24,914 1,961 8.54 379 -3.57 0.0010
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 22,953 5,127 28.76 392 163.09 0.0012
2023-11-13 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 17,826 -21 -0.12 149 -66.37 0.0005
2023-08-10 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 17,847 2,171 13.85 443 88.51 0.0013
2023-05-26 2023-03-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 15,676 -1,453 -8.48 236 16.34 0.0007
2023-05-12 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 15,676 -1,453 236 0.0007
2023-02-02 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 17,129 2,443 16.63 203 132.18 0.0007
2022-11-07 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 14,686 -277 -1.85 87 35.94 0.0003
2022-08-01 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 14,963 -9,332 -38.41 64 -72.29 0.0002
2022-05-10 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 24,295 -4,002 -14.14 231 -56.98 0.0005
2022-02-08 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 28,297 11,869 72.25 537 -1.83 0.0011
2021-11-12 2021-09-30 13F TG THERAPEUTICS COM 88322Q108 16,428 -16,828 -50.60 547 -57.60 0.0015
2021-08-13 2021-06-30 13F TG THERAPEUTICS COM 88322Q108 33,256 711 2.18 1,290 -17.78 0.0038
2021-05-14 2021-03-31 13F TG THERAPEUTICS COM 88322Q108 32,545 7,007 27.44 1,569 18.15 0.0049
2021-02-09 2020-12-31 13F TG THERAPEUTICS COM 88322Q108 25,538 11,925 87.60 1,328 264.84 0.0049
2020-11-13 2020-09-30 13F TG THERAPEUTICS COM 88322Q108 13,613 485 3.69 364 42.19 0.0017
2020-08-03 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 13,128 13,128 256 0.0014
2020-05-15 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 0 -11,682 -100.00 0 -100.00
2020-02-12 2019-12-31 13F TG THERAPEUTICS COM 88322Q108 11,682 11,682 130 0.0006
2014-11-06 2014-09-30 13F TG THERAPEUTICS COM 88322Q108 0 -11,442 -100.00 0 -100.00
2014-08-08 2014-06-30 13F TG THERAPEUTICS COM 88322Q108 11,442 -4,296 -27.30 107 -1.83 0.0014
2014-05-07 2014-03-31 13F TG THERAPEUTICS COM 88322Q108 15,738 15,738 109 0.0014
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.